IRCT20230221057485N1招募中2 期
Investigation of the effect of adding Desloratadine to neoadjuvant chemotherapy on the response to treatment and some of inflammatory factors in breast cancer patients
Gorgan University of Medical Sciences0 个研究点目标入组 104 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Newly diagnosed breast cancer who are candidates for neoadjuvant chemotherapy (including patients with axillary lymphadenopathy, infraclavicular and supraclavicular lymphadenopathy/tumor size greater than 2 cm in triple-negative and Her2-enriched patients/skin involvement/inflammatory breast cancer and a large ratio of tumor to total breast).
- •Not using antihistamines (anti-H1R and H2R receptors)
- •Not having other cancers at the same time as breast cancer
排除标准
- •Patients with immunological disorders
- •Patients who are not eligible for chemotherapy
- •Patients who have undergone breast surgery
研究者
相似试验
已完成
2 期
Comparing the effectiveness of combination therapy and monotherapy on quality of life in patients with persistent allergic rhinitisallergic rhinitis.Vasomotor and allergic rhinitisIRCT20200909048677N1Kashan University of Medical Sciences56
进行中（未招募）
不适用
Combined treatment of cinnarizine and iprazochrome in urticaria factitiaEUCTR2012-004002-10-HUDepartment of Dermatology and Allergology, University of Szeged
尚未招募
不适用
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N40Darou darman Pars Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N60Actover Pharmaceutical Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N61Darou darman Arang24